Semaglutide is mostly well tolerated with equivalent dropout charges when compared with placebo, even though it may be fewer effectively tolerated than dulaglutide (Trulicity).1,three The most typical adverse outcomes are nausea, vomiting, and diarrhea and can be expert by about 30% of patients, generally once the dose is amplified.Our products are